Sustained virological response: A milestone in the treatment of chronic hepatitis C

被引:69
|
作者
Morisco, Filomena [1 ]
Granata, Rocco [1 ]
Stroffolini, Tommaso [2 ]
Guarino, Maria [1 ]
Donnarumma, Laura [1 ]
Gaeta, Laura [1 ]
Loperto, Ilaria [1 ]
Gentile, Ivan [3 ]
Auriemma, Francesco [1 ]
Caporaso, Nicola [1 ]
机构
[1] Univ Naples Federico II, Dipartimento Med Clin & Chirurg, Gastroenterol Unit, I-80131 Naples, Italy
[2] Univ Roma La Sapienza, Dipartimento Malattie Infett & Trop, I-00161 Rome, Italy
[3] Univ Naples Federico II, Dipartimento Med Clin & Chirurg, Infect Dis Unit, I-80131 Naples, Italy
关键词
Antiviral therapy; Cirrhosis; Hepatitis C virus; Sustained virological response; Fibrosis; TERM-FOLLOW-UP; HEPATOCELLULAR-CARCINOMA; INTERFERON THERAPY; LIVER FIBROSIS; ANTIVIRAL THERAPY; RIBAVIRIN; CIRRHOSIS; OUTCOMES; ALPHA; INFECTION;
D O I
10.3748/wjg.v19.i18.2793
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To evaluate the long-term eradication of hepatitis C virus (HCV) infection and liver-related complications in chronically infected patients that have achieved sustained virological response. METHODS: One hundred and fifty subjects with chronic hepatitis C (CHC) or cirrhosis and sustained virological response (SVR) between the years of 1989 and 2008 were enrolled in a long-term clinical follow-up study at the Gastrointestinal and Liver Unit of the University Hospital of Naples "Federico.". At the beginning of the study, the diagnosis of HCV infection was made on the basis of serum positivity for antibodies to HCV and detection of HCV RNA transcripts, while a diagnosis of chronic hepatitis was formulated using imaging techniques and/or a liver biopsy. SVR was achieved by interferon-based therapy, both conventional and pegylated, with and without ribavirin treatment. The patients were evaluated for follow-up at a median length of 8.6 years, but ranged from 2-19.9 years. Among them, 137 patients had pre-treatment CHC and 13 had cirrhosis. The patients were followed with clinical, biochemical, virological, and ultrasound assessments on a given schedule. Finally, a group of 27 patients underwent a liver biopsy at the beginning of the study and transient elastography at their final visit to evaluate changes in liver fibrosis. RESULTS: The median follow-up was 8.6 years (range 2-19.9 years). HCV RNA remained undetectable in all patients, even in patients who eventually developed liver-related complications, indicating no risk of HCV recurrence. Three liver-related complications were observed: two cases of hepatocellular carcinoma and one case of bleeding from esophageal varices resulting in an incidence rate of 0.23%/person per year. Further, all three complications took place in patients diagnosed with cirrhosis before treatment began. Only one death due to liver-related causes occurred, resulting in a mortality rate of 0.077% person per year. This amounts to a 99.33% survival rate in our cohort of patients after therapy for HCV infection. Finally, of the 27 patients who underwent a liver biopsy at the beginning of the study, a reduction in liver fibrosis was observed in 70.3% of the cases; only three cases registering values of liver stiffness indicative of significant fibrosis. CONCLUSION: Patients with CHC and SVR show an excellent prognosis with no risk of recurrence and a very low rate of mortality. Our data indicate that viruseradication following interferon treatment can last up to 20 years. (C) 2013 Baishideng. All rights reserved.
引用
收藏
页码:2793 / 2798
页数:6
相关论文
共 50 条
  • [1] Sustained virological response: A milestone in the treatment of chronic hepatitis C
    Filomena Morisco
    Rocco Granata
    Tommaso Stroffolini
    Maria Guarino
    Laura Donnarumma
    Laura Gaeta
    Ilaria Loperto
    Ivan Gentile
    Francesco Auriemma
    Nicola Caporaso
    World Journal of Gastroenterology, 2013, 19 (18) : 2793 - 2798
  • [2] Sustained Virological Response to Treatment in Patients With Chronic Hepatitis C
    Maisonneuve, Patrick
    Bruno, Savino
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (14): : 1457 - 1457
  • [3] The Factors Affecting the Sustained Virological Response in Chronic Hepatitis C Treatment
    Gurbuz, Yunus
    Tutuncu, Ediz
    Ozturk, Baris
    Kuscu, Ferit
    Sencan, Irfan
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2008, 13 (03): : 106 - 110
  • [4] Sustained Virological Response to Treatment of Chronic Hepatitis C in Midwest, Brazil
    Scariott, Mirian
    Oliveira, Sandra M. V. L.
    Matos, Vanessa T. G.
    Uehara, Silvia N. O.
    Paniago, Anamaria M. M.
    LATIN AMERICAN JOURNAL OF PHARMACY, 2014, 33 (02): : 204 - 209
  • [5] Predictive factors for sustained virological response in the treatment of patients with chronic hepatitis C
    Svirtlih, N.
    Delic, D.
    Somonovic, J.
    Radovanovic, A.
    Mitrovic, N.
    Nikitovic, L.
    Gvozdenovic, E.
    Zerjav, S.
    Boricic, I.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : E232 - E232
  • [6] Sustained virological response to treatment of chronic hepatitis C with peginterferon alfa and ribavirin
    da Rosa, Junior Andre
    Blatt, Carine Raquel
    Peres, Kaite Cristiane
    Storb, Bernd Heinrich
    Silva, Rochele
    Farias, Mareni Rocha
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 48 (02) : 193 - 201
  • [7] Sustained Virological Response in Diabetic Patients with Chronic Hepatitis C
    Dogan, Umit B.
    Akin, Mustafa S.
    Camuz, Gunay
    HEPATOLOGY, 2014, 60 : 704A - 704A
  • [8] Chronic Hepatitis C, Sustained Virological Response and Overall Survival
    Krome, Susanne
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2013, 51 (05): : 418 - 418
  • [9] Sustained virological response following chronic hepatitis C treatment improves insulin resistance
    Chan, C. H. Y.
    Hansen, R. D.
    Jones, B. E.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A301 - A301
  • [10] SUSTAINED VIROLOGICAL RESPONSE FOLLOWING CHRONIC HEPATITIS C TREATMENT IMPROVES INSULIN RESISTANCE
    Chan, Calvin H.
    Hansen, Ross D.
    Jones, Brett E.
    HEPATOLOGY, 2009, 50 (04) : 920A - 920A